Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin
US-10705076-B2 · Jul 7, 2020 · US
This page is not indexed by search engines while we improve data quality.
Drocourt Daniel patents
Drocourt Daniel is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Drocourt Daniel |
| Total patents | 6 |
| First publication | Feb 5, 2015 |
| Latest publication | Jul 7, 2020 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
US-2019135924-A1 · May 9, 2019 · US
Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
US-9637538-B2 · May 2, 2017 · US
Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy
US-9364494-B2 · Jun 14, 2016 · US
Combination products for treating cancer
US-2015190480-A1 · Jul 9, 2015 · US
Anti-hla monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin
US-2015037819-A1 · Feb 5, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Cayla | 5 |
| Univ Toulouse 3 Paul Sabatier | 4 |
| Ct Hospitalier Universitaire Toulouse | 4 |
| Invivogen | 3 |
| Inst Nat Sante Rech Med | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/2833 | 4 |
| C07K2317/24 | 4 |
| G01N33/6854 | 3 |
| G01N33/6893 | 3 |
| A61P35/00 | 2 |